Has the use of concomitant cardiac medications improved over time in primary prevention ICD patients? Insights from the APPRAISE ATP study

Authors

L. Mont
J. Daubert
V. Kutyifa
W. Zareba
K. Ando
N. Wold
P. Yong
Claudio Schuger, Henry Ford HealthFollow

Recommended Citation

Mont L, Daubert J, Kutyifa V, Zareba W, Ando K, Wold N, Yong P, Schuger C. Has the use of concomitant cardiac medications improved over time in primary prevention ICD patients? Insights from the APPRAISE ATP study. Eur Heart J 2023; 44:2.

Document Type

Conference Proceeding

Publication Date

11-9-2023

Publication Title

Eur Heart J

Volume

44

First Page

2